Clinical Trial Update: Acute Hip Fracture Study in Patients 65 Years or Greater [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on an acute hip fracture study in patients aged 65 and older; the study is completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Fracture

Drugs mentioned

• Not disclosed

Snippet

Sponsor: Viking Therapeutics, Inc. | Conditions: Hip Fractures | Phase 2 | Status: COMPLETED | Results posted: 2025-12-29